Intralesional immunotherapy compared to cryotherapy in the treatment of warts.

Immunotherapy

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

JAMA.

Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, Sever ML, Bahnson HT, Lawson K, Harris KM, Plough AG, Panza JL, Qin T, Lim N, Tchao NK, Togias A, Durham SR

doi: 10.1001/jama.2016.21040.

Immunotherapy

Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy

Clin Rev Allergy Immunol.

Scurlock AM

doi: 10.1007/

Allergic DiseasesImmunotherapy

Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in egg-allergic children

J Allergy Clin Immunol.

Kim EH, Perry TT, Wood RA, Leung DY, Berin MC, Burks AW, Cho CB, Jones SM, Scurlock A, Sicherer SH, Henning AK, Dawson P, Lindblad RW, Plaut M, Sampson HA, Consortium for Food Allergy Research (CoFAR)

doi: 10.1016/j.jaci.2020.05.040.

Psoriasis

Ixekizumab provides superior efficacy compared to ustekinumab over 52-weeks of treatment: results from IXORA-S, a phase 3 study

J Am Acad Dermatol.

Paul C, Griffiths CEM, van de Kerkhof PCM, Puig L, Dutronc Y, Henneges C, Dossenbach M, Hollister K, Reich K

doi: 10.1016/j.jaad.2018.06.039.

Immunotherapy

Treatment after progression in the era of immunotherapy

Lancet Oncol

Billan S, Kaidar-Person O, Gil Z

doi: 10.1016/S1470-2045(20)30328-4

A real-world, community-based cohort study comparing the effectiveness of topical fluoruracil vs. topical imiquimod for the treatment of actinic keratosis

J Am Acad Dermatol.

Neugebauer R, Levandoski KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM

doi: 10.1016/j.jaad.2017.12.042.

Allergic Diseases

Personalized Medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model

Allergy.

Incorvaia C, Al-Ahmad M, Ansotegui I, Arasi S, Bachert C, Bos C, Bousquet J, Bozek A, Caimmi D, Calderón M, Casale T, Custovic A, De Blay F, Demoly P, Devillier P, Didier A, Fiocchi A, Fox A, Gevaert P, Gomez M, Heffler E, Ilina N, Irani C, Jutel M, Karagiannis E, Klimek L, Kuna P, O'Hehir R, Kurbacheva O, Matricardi PM, Morais de Almeida M, Mosges R, Novak N, Okamoto Y, Panzner P, Papadopoulos N, Park HS, Passalacqua G, Pawankar R, Pfaar O, Schmid-Grendelmeier P, Scurati S, Tortajada-Girbés M, Vidal C, Virchow C, Wahn U, Worm M, Zieglmayer P, Canonica GW

doi: 10.1111/all.14575.

Immunotherapy

Risk factors and treatment outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER)

J Allergy Clin Immunol Pract.

Goldberg MR, Nachshon L, Levy MB, Elizur A, Katz Y

doi: 10.1016/j.jaip.2019.07.034.

Psoriasis

Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naïve to systemic treatment: Results from a randomised, active comparator-controlled phase 3b trial (POLARIS)

Br J Dermatol.

Thaҫi D, Pinter A, Sebastian M, Termeer C, Sticherling M, Gerdes S, Wegner S, Krampe S, Bartz H, Rausch C, Mensch A, Eyerich K

doi: 10.1111/bjd.18696.

Related content

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy

Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in egg-allergic children

Ixekizumab provides superior efficacy compared to ustekinumab over 52-weeks of treatment: results from IXORA-S, a phase 3 study

Treatment after progression in the era of immunotherapy

A real-world, community-based cohort study comparing the effectiveness of topical fluoruracil vs. topical imiquimod for the treatment of actinic keratosis

Personalized Medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model

Risk factors and treatment outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER)

Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naïve to systemic treatment: Results from a randomised, active comparator-controlled phase 3b trial (POLARIS)